Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov:321:26-34.
doi: 10.1016/j.cellimm.2017.04.012. Epub 2017 Jul 11.

T-bet-expressing B cells during HIV and HCV infections

Affiliations
Review

T-bet-expressing B cells during HIV and HCV infections

James J Knox et al. Cell Immunol. 2017 Nov.

Abstract

T-bet-expressing B cells, first identified as perpetuators of autoimmunity, were recently shown to be critical for murine antiviral responses. While their role in human viral infections remains unclear, B cells expressing T-bet or demonstrating a related phenotype have been described in individuals chronically infected with HIV or HCV, suggesting these cells represent a component of human antiviral responses. In this review, we discuss the induction of T-bet in B cells following both HIV and HCV infections, the factors driving T-bet+ B cell expansions, T-bet's relationship to atypical memory B cells, and the consequences of T-bet induction. We propose potential antiviral roles for T-bet+ B cells and discuss whether this population poses any utility to the HIV and HCV immune responses.

Keywords: B cells; HCV; HIV; Humoral immunology; T-bet.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
T-bet expression by B cell subsets of a healthy human donor. (A) Total B cells, defined by CD19 expression, from the peripheral blood mononuclear cells of an HIV-negative, HCV-negative human donor are depicted. Gates display the identification of naïve (black), resting memory (blue), and CD21-negative (purple) B cell subsets. (B) CD21-negative B cells are separated into CD85j high (red) and CD85j low (grey) subsets. (C) Histogram depicting T-bet expression of the aforementioned B cell subsets.
Fig. 2
Fig. 2
Model proposing the induction and differentiation of T-bet-expressing B cells by viral infections. T-bet is induced in B cells following TLR/cytokine/BCR stimulation during acute viral infection, leading to T-bethighCD21CD85jhigh subset development. Upon viral clearance (yellow fever virus (YFV) and vaccinia virus (VV) vaccinations), the blood T-bethigh subset contracts in size, potentially due to trafficking of cells into tissues, differentiation into a resting phenotype (T-betlow), or cell death. However, during chronic HIV and HCV infections, persistent viral replication and immune activation induces expansion and maintenance of a large T-bethigh B cell pool. Individuals cured of HCV offer a unique opportunity to assess the fate of HCV-induced T-bet+ B cells following antigen clearance.

References

    1. Lazarevic V, Glimcher LH, Lord GM. T-bet: a bridge between innate and adaptive immunity. Nat Rev Immunol. 2013;13(11):777–789. - PMC - PubMed
    1. Beima KM, Miazgowicz MM, Lewis MD, Yan PS, Huang TH, Weinmann AS. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J Biol Chem. 2006;281(17):11992–12000. - PubMed
    1. Oestreich KJ, Weinmann AS. T-bet employs diverse regulatory mechanisms to repress transcription. Trends Immunol. 2012;33(2):78–83. - PMC - PubMed
    1. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100(6):655–669. - PubMed
    1. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000;1(6):475–482. - PubMed